| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
2e-17 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.41 |
6e-15 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
4e-12 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-11 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |